A synthetic pentapeptide growth-hormone secretagogue with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 (CAS 170851-70-4), developed by Novo Nordisk under code NNC 26-0161. Selectively agonizes the ghrelin/GHS-R1a receptor to trigger pulsatile GH release with minimal effect on cortisol, ACTH, or prolactin — a cleaner selectivity profile than older GHRPs (GHRP-2, GHRP-6). Studied in Phase 2 for post-operative ileus; development discontinued. Commonly paired with CJC-1295 in research protocols to combine ghrelin-receptor and GHRH-receptor pathways.
For research purposes only. Not medical advice.
EZ Peptides currently lists Ipamorelin at $3.50/mg, the lowest indexed price across 19 tracked research peptide vendors.
Ipamorelin ranges from $3.50/mg to $10.00/mg across 23 listings from 19 research peptide vendors, normalized to USD per milligram and refreshed daily.
19 research peptide vendors currently list Ipamorelin on PeptideScouter, with 18 in stock right now. We track 23 active listings across size and kit variants.
Ipamorelin's CAS Registry Number is 170851-70-4. It is also sold as Ipamo.